America February 17, 2026
Portland General to Buy PacifiCorp in $1.9B Power Deal
Portland General Electric Company (PGE) and Manulife Investment Management have struck a $1.9 billion cash deal to acquire PacifiCorp’s Washington…
Rachel Moore is a staff writer and journalist for the USA Herald, where she specializes in high-impact reporting on international conflicts, economic shifts, and scientific advancements. With a keen eye for detail and a commitment to "The People’s Media."
America February 17, 2026
Portland General Electric Company (PGE) and Manulife Investment Management have struck a $1.9 billion cash deal to acquire PacifiCorp’s Washington…
By Rachel Moore
America February 13, 2026
A Philadelphia jury has delivered a sharp rebuke to Johnson & Johnson, handing down a $250,000 verdict Friday in a…
By Rachel Moore
America February 13, 2026
In a move that reshapes the U.S. homebuilding map like a master developer redrawing blueprints, Sumitomo Forestry Co. Ltd. announced…
By Rachel Moore
America February 13, 2026
Weedmaps Technology Inc. disclosed Thursday that it has reached an agreement in principle to settle a proposed investor class action…
By Rachel Moore
America February 10, 2026
A federal appeals court has upheld the NYT Auto-Renewal Class Deal, rejecting claims that a $2.375 million settlement resolving allegations…
By Rachel Moore
America February 10, 2026
A federal judge has rejected a special master’s attempt to force Venezuela and a gold mining company to absorb a…
By Rachel Moore
America February 10, 2026
Clear Channel Outdoor Holdings Inc. is set to leave the public markets after agreeing to be taken private in a…
By Rachel Moore
America February 9, 2026
A years-old ransomware attack is back in the spotlight as State Street Bank takes aim at its former human resources…
By Rachel Moore
America February 9, 2026
In a move that underscores the escalating arms race in artificial intelligence, the Amazon STMicro Deal commits Amazon Web Services…
By Rachel Moore
America February 9, 2026
In a move that underscores Big Pharma’s race to harness next-generation genetic medicine, Eli Lilly to buy Orna Therapeutics in…
By Rachel Moore